Highlights
Highlights
❰❱
Neueste Storys
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Oberösterreichische Landesbank Aktiengesellschaft
EANS-Adhoc: S&P Global Ratings (S&P) revised outlook of Oberösterreichische Landesbank AG (HYPO Oberösterreich) from stable to positive; Ratings A/A-1 affirmed
issuer: Oberösterreichische Landesbank Aktiengesellschaft Landstraße 38 A-4020 Linz phone: +43(0)732/7639 WWW: www.hypo.at sector: Banking ISIN: - indexes: stockmarkets: stock market: Luxembourg Stock Exchange, Wien, SIX Swiss Exchange language: English ...
mehrTurkish Airlines Takes Surprise David Guetta UEFA EURO 2016(TM) Anthem to Swiss Fans with Unique Video
Istanbul (ots/PRNewswire) - Turkish Airlines, Europe's best airline for five consecutive years*, this week takes David Guetta's UEFA EURO 2016(TM) anthem to the 24 competing nations in this year's tournament. Football and David Guetta fans in Switzerland can enjoy their bespoke music video ...
mehrEQS-Adhoc: Kuros Bioscience's Shareholders Approve All Resolutions
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): AGM/EGM Kuros Bioscience's Shareholders Approve All Resolutions 16.06.2016 / 14:38 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 472175 16.06.2016 ...
mehrUnited Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems
Sunnyvale, California (ots/PRNewswire) - Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a new partnership designed to provide clinicians and their patients with additional ...
mehrCopernicus Atmosphere Monitoring Service (CAMS)
Copernicus Atmosphere Monitoring Service (CAMS) Announces a Major Improvement on Atmosphere Data Accessibility
Athens, Greece (ots/PRNewswire) - At the first CAMS summit in Athens on 14-16 June, ECMWF, in charge of CAMS on behalf of the European Commission, will launch a radically new interactive and ready to use version of its online platform of atmosphere data. Policy makers, scientific and business communities or citizens ...
mehrBookingSuite's New RateIntelligence Product Provides Access to Unique Market Demand and Rate Shopping Data up to 360 Days in Advance
Amsterdam (ots/PRNewswire) - Accommodation providers can now get started with reliable demandand competitor pricing insights for their property in just minutes Today BookingSuite, a company within the Booking.com group of companies, announced the global release of RateIntelligence, a new market intelligence tool. ...
mehr
EANS-Adhoc: ams AG / ams acquires CCMOSS to become world leader in gas and infrared sensing
issuer: ams AG Tobelbader Strasse 30 A-8141 Unterpremstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com sector: Technology ISIN: AT0000A18XM4 indexes: stockmarkets: official dealing: SIX Swiss Exchange language: English ...
mehrEQS-Adhoc: AEVIS VICTORIA SA - General Meeting of Shareholders: all proposals approved
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): AGM/EGM AEVIS VICTORIA SA - General Meeting of Shareholders: all proposals approved 14.06.2016 / 17:32 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 471491 14.06.2016 ...
mehrCastrol EDGE Introduces the Next Episode of its World Famous Titanium Trials With #CloneRival
London (ots/PRNewswire) - Clone Rival: Supercar racers take on fastest driving trial yet. Challenged on the track to beat their digital clone. Castrol EDGE Titanium Trial: #CloneRival http://castrl.co/CloneRivalAM http://castrl.co/CloneRivalK - Two world class-racing drivers meet their ultimate race track rivals... themselves. - Drivers trained virtually at Titanium ...
mehrInag-Nievergelt AG joins BKW / BKW expands its building technology installation business
mehrVictoza® significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial
New Orleans (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced that Victoza® (liraglutide) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal ...
mehrRichmont Mines Added to the S&P/TSX Global Mining Index and the S&P/TSX Global Gold Index
Toronto (ots/PRNewswire) - Richmont Mines Inc. (TSX - NYSE MKT: RIC) ("Richmont" or the "Corporation") is pleased to announce that it will be added to the S&P/TSX Global Mining Index and the S&P/TSX Global Gold Index, effective after the close of trading on Friday, June 17, 2016. S&P Dow Jones Canadian Index Services announced this addition on June 10, 2016, following ...
mehr
Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRapid® (insulin aspart)
New Orleans (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstracts: 293-OR, 240-OR Faster-acting insulin aspart improved postprandial glucose (PPG) control in type 1 and type 2 diabetes New phase 3a findings showed that ...
mehrAuRico Metals Provides Management Update
Toronto (ots/PRNewswire) - AuRico Metals Inc. (TSX: AMI) ("AuRico" or the "Company") is pleased to announce the appointment of John Miniotis as Vice President, Corporate Development and the appointment of David Flahr as Vice President, Finance. Both appointments are effective June 13, 2016. Mr. Miniotis is joining AuRico Metals from Lundin Mining where he played a leading role advancing their M&A (mergers and ...
mehrAtradius: World Economy 'Slower for Longer', Warns for Insolvencies in Eurozone Periphery
Amsterdam (ots/PRNewswire) - The Atradius outlook for global economic growth is 'slower for longer', with five primary downside risks that could drag down the economic and insolvency outlooks. (Logo: http://photos.prnewswire.com/prnh/20150513/743985 ) While the turbulence experienced in the first months of 2016 has subsided the underlying issues persist. Low commodity ...
mehrMerck in Agreement with HAPPYneuron to Offer First-of-its-Kind e-Health Solution for People Living with Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - Agreement provides Merck with exclusive license to cognitive remediation training programs - HAPPYneuron will be available for inclusion in Merck's MSdialog platform for use with Rebif® (interferon beta-1a) Merck, a leading science and technology company, announced today that ...
mehrSemaglutide Demonstrated Superior Improvements in Glycaemic Control vs Sitagliptin (SUSTAIN 2) and Exenatide ER (SUSTAIN 3) in Two Clinical Trials in Adults With Type 2 Diabetes
New Orleans (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstracts 185-OR and 187-OR Findings from two phase 3a clinical trials for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, were presented ...
mehrSuccessful Switch to Sanofi's Toujeo® Evaluated in a Real-World Setting
Paris (ots/PRNewswire) - Sanofi announced today the release of the new real world data assessing the use of Toujeo® (insulin glargine injection 300 Units/mL). The U.S. Predictive Health Intelligence Environment (PHIE) database, containing a substantial amount of patient level information, was analyzed to assess Toujeo in this real life setting. The study examined ...
mehr
Tresiba® (insulin degludec injection U-100) demonstrated significantly lower rates of overall, nocturnal and severe hypoglycaemia vs insulin glargine U-100
New Orleans (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstracts 87-LB and 90-LB New findings from the two phase 3b SWITCH trials showed that treatment with long-acting basal insulin Tresiba® (insulin degludec injection ...
mehrShire Pharmaceuticals Group Plc
Shire Announces Completion of Decentralized Procedure in Europe for Immunoglobulin Treatment Cuvitru
Zug, Switzerland (ots/PRNewswire) - - Cuvitru (IG 20mg/ml solution for subcutaneous injection) builds on company's broad portfolio of IG treatments gained through combination with Baxalta - New option to treat primary and certain secondary immunodeficiencies can help meet patient needs related to number of infusion ...
mehrEQS-Adhoc: SANDPIPER Digital Payments AG announces annual figures for 2015
EQS Group-Ad-hoc: Sandpiper Digital Payments AG / Key word(s): Final Results/AGM/EGM SANDPIPER Digital Payments AG announces annual figures for 2015 10.06.2016 / 20:00 Release of an ad hoc announcement pursuant to Art. 18 KR. The issuer is solely responsible for the content of this announcement. 470853 10.06.2016 ...
mehrViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV
London (ots/PRNewswire) - Reduction of weight limit to at least 30kg means more children and adolescents will be eligible for dolutegravir ViiV Healthcare today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral ...
mehrUCB's bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis
Brussels (ots/PRNewswire) - - Bimekizumab is a highly selective monoclonal antibody that inhibits the activity of both IL-17A and IL-17F, key pro-inflammatory cytokines expressed in several inflammatory diseases[1],[2] - In this early proof of concept study, bimekizumab showed fast and sustained efficacy on disease ...
mehrFirst ever exclusive live Bundesliga matches on Eurosport in Germany
München (ots) - - DFL Deutsche Fußball Liga awards Eurosport exclusive rights to show regular Friday night primetime, selected Sunday afternoon and top Monday night Bundesliga matches on Eurosport paid platforms in Germany - Four year agreement will see 40 live Bundesliga matches per season presented exclusively on Eurosport from 2017/18 - Matches also available ...
mehr
Hydro-Québec's Strategic Plan 2016-2020 - Hydro-Québec is Poised to Attract Data Centres
Montréal (ots/PRNewswire) - Hydro-Québec has announced a move to attract data centres to Québec. The decision is in line with one of the objectives outlined in its Strategic Plan 2016-2020, namely to lay the groundwork to double the company's revenue over the next 15 years. "The global data centre market is rapidly growing and we have what it takes to be at the ...
mehrDGAP-News: LION E-Mobility AG: Join Venture 'TÜV SÜD Battery Testing GmbH' receives grant in highly remunerated EU funding project
DGAP-News: LION E-Mobility AG / Key word(s): Incoming Orders/Joint Venture LION E-Mobility AG: Join Venture 'TÜV SÜD Battery Testing GmbH' receives grant in highly remunerated EU funding project 08.06.2016 / 14:34 The issuer is solely responsible for the content of this announcement. 470161 08.06.2016 ...
mehrUCB Commitment to Addressing Real World Patient Needs on Display at the Annual European Congress of Rheumatology (EULAR 2016)
Brussels (ots/PRNewswire) - For medical and trade media only. New data highlight breadth of UCB's pioneering portfolio with four molecules across five indications: - An oral presentation of data from the two year C-EARLY(TM) Phase 3 study of Cimzia®, exploring different dosing strategies - Oral presentations from ...
mehrDebiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1143 in Ovarian Cancer
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm today announced the start of a phase II clinical trial for Debio 1143 in combination with standard of care Carboplatin and Paclitaxel in Epithelial Ovarian Cancer Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global ...
mehrD+H Joins Blockchain Panel at EBAday Conference
New York (ots/PRNewswire) - DH Corporation (http://dh.com/) (TSX: DH) ("D+H"), a leading provider of technology solutions to financial institutions globally, today announced that Gene Neyer, D+H's head of product, global payments, will join a panel titled "How Mainstream Can Blockchain Be?" at EBAday, a leading forum covering the key trends impacting the payments industry, on June 7 in Milan, Italy. The panel, which ...
mehrNovo Nordisk to Present 53 Abstracts at 76th Annual American Diabetes Association Scientific Sessions in New Orleans, LA
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk, a global leader in diabetes care, today announced that data from 53 abstracts including 8 oral presentations will be shared at the upcoming 76th ...
mehr